Bevacizumab-induced diffusion-restricted lesions in malignant glioma patients

By Rieger Johannes   Bähr Oliver   Müller Klaus   Franz Kea   Steinbach Joachim   Hattingen Elke  

Journal of Neuro-Oncology, Vol. 99, Iss. 1, 2010-08 ,pp. : 49-56

Springer Publishing Company

Access to resources Recommend Favorite

Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct subgroups of pediatric diffuse intrinsic pontine glioma

By Lober Robert   Cho Yoon-Jae   Tang Yujie   Barnes Patrick   Edwards Michael   Vogel Hannes   Fisher Paul   Monje Michelle   Yeom Kristen  

Journal of Neuro-Oncology, Vol. 117, Iss. 1, 2014-03 ,pp. : 175-182

Springer Publishing Company

Access to resources Recommend Favorite

MR perfusion and diffusion imaging for the diagnosis of benign and malignant bone tumors

By Sun Meiyu  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 6, 2008-06 ,pp. : 352-357

Springer Publishing Company

Access to resources Recommend Favorite

Predictive significance of mean apparent diffusion coefficient value for responsiveness of temozolomide-refractory malignant glioma to bevacizumab: preliminary report

By Nagane Motoo   Kobayashi Keiichi   Tanaka Masaki   Tsuchiya Kazuhiro   Shishido-Hara Yukiko   Shimizu Saki   Shiokawa Yoshiaki  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 16-23

Springer Publishing Company

Access to resources Recommend Favorite

Targeting integrins in malignant glioma

By Tabatabai Ghazaleh  

Targeted Oncology, Vol. 5, Iss. 3, 2010-09 ,pp. : 175-181

Springer Publishing Company

Access to resources Recommend Favorite